SELLAS Life Sciences Group, Inc. (SLS)
3.73
+0.20
(+5.67%)
USD |
NASDAQ |
Feb 06, 16:00
3.75
+0.02
(+0.54%)
After-Hours: 20:00
SELLAS Life Sciences Group SG&A Expense (TTM) : 11.21M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| GT Biopharma, Inc. | 6.564M |
| Amicus Therapeutics, Inc. | 353.07M |
| Geron Corp. | 160.96M |
| Vanda Pharmaceuticals, Inc. | 214.26M |
| ADMA Biologics, Inc. | 96.37M |